Arcadia Biosciences (RKDA) to Participate in Upcoming Investor Conferences

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc.^® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that Stan Jacot, president and CEO and T.J. Schaefer, CFO, will be participating in two investor conferences during the month of September.

• H.C. Wainwright 25^th Annual Global Investment Conference. Arcadia will be featured as a presenting company at the conference, to be held September 11-13, 2023 at the Lotte Palace Hotel in New York City. Stan Jacot, Arcadia’s president and CEO will present a business overview at 4:00 p.m. ET on Tuesday, September 12 and will be available for in-person meetings with investors. Institutional investors may request a meeting by registering for the conference at www.hcwevents.com/annualconference.
• Lake Street Capital Markets’ 7^th Annual Best Ideas Growth (BIG7) Conference. Arcadia will also be conducting one-on-one investor meetings at Lake Street’s BIG7 Conference on Thursday, September 14, 2023 at the Yale Club in New York City.

Jacot’s H.C. Wainwright presentation will be webcast live here, and a replay will be available in the Investors section of the Arcadia’s website.

About Arcadia Biosciences

Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating crops to provide high-value, healthy ingredients to meet consumer demands for healthier choices. With its roots in agricultural innovation, Arcadia cultivates next-generation wellness products that make every body feel good. The company’s food and beverage products include GoodWheat™ pasta and pancake mixes and Zola^® coconut water. For more information, visit www.arcadiabio.com.